Teligent Pharma, Inc. is recalling 20,160 tubes of Clobetasol Propionate Ointment USP 0.05% (50g) because the product may be superpotent or subpotent. Testing revealed low and high assay results, meaning the medication may contain more or less of the active ingredient than specified. Consumers using this prescription topical steroid should contact their healthcare provider or pharmacist regarding the effectiveness and safety of their current supply.
The ointment was found to have inconsistent potency levels; superpotent batches may increase the risk of side effects like skin thinning or systemic absorption, while subpotent batches may not effectively treat the skin conditions for which they were prescribed.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.